148 related articles for article (PubMed ID: 29745043)
1. Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancer.
Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Komaki R; Hu Y; Hahn SM; Liao Z
Cancer Med; 2018 Jun; 7(6):2247-2255. PubMed ID: 29745043
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.
Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Hahn S; Liao Z
Oncotarget; 2017 Jun; 8(26):43080-43090. PubMed ID: 28574846
[TBL] [Abstract][Full Text] [Related]
3. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
4. TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.
Yuan X; Wei Q; Komaki R; Liu Z; Yang J; Tucker SL; Xu T; Heymach JV; Lu C; Cox JD; Liao Z
PLoS One; 2013; 8(6):e65659. PubMed ID: 23840350
[TBL] [Abstract][Full Text] [Related]
5. Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.
Wen J; Liu H; Wang L; Wang X; Gu N; Liu Z; Xu T; Gomez DR; Komaki R; Liao Z; Wei Q
J Thorac Oncol; 2018 May; 13(5):660-675. PubMed ID: 29454863
[TBL] [Abstract][Full Text] [Related]
6. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665
[TBL] [Abstract][Full Text] [Related]
7. Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
Ye L; Shi S; Zeng Z; Huang Y; Hu Y; He J
Jpn J Clin Oncol; 2018 Feb; 48(2):160-166. PubMed ID: 29253245
[TBL] [Abstract][Full Text] [Related]
8. Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapy.
Wang H; Liao Z; Zhuang Y; Liu Y; Levy LB; Xu T; Yusuf SW; Gomez DR
Clin Lung Cancer; 2015 Mar; 16(2):128-36. PubMed ID: 25450873
[TBL] [Abstract][Full Text] [Related]
9. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
Wang HM; Liao ZX; Komaki R; Welsh JW; O'Reilly MS; Chang JY; Zhuang Y; Levy LB; Lu C; Gomez DR
Ann Oncol; 2013 May; 24(5):1312-9. PubMed ID: 23300016
[TBL] [Abstract][Full Text] [Related]
10. [Technical advancement improves survival in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiotherapy].
Wang JB; Jiang W; Ji Z; Cao JZ; Liu LP; Men Y; Xu C; Wang XZ; Hui ZG; Liang J; Lyu JM; Zhou ZM; Xiao ZF; Feng QF; Chen DF; Zhang HX; Yin WB; Wang LH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):607-14. PubMed ID: 27531481
[TBL] [Abstract][Full Text] [Related]
11. Nomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patients.
Zhang B; Yuan Z; Zhao L; Pang Q; Wang P
Oncotarget; 2017 Jun; 8(23):37208-37216. PubMed ID: 28388538
[TBL] [Abstract][Full Text] [Related]
12. Definitive concurrent chemoradiotherapy outcomes in Stage IIIB nonsmall cell lung cancer patients younger than 45 years: A retrospective analysis of 145 patients.
Topkan E; Guler OC; Ozdemir Y
J Cancer Res Ther; 2020; 16(4):757-763. PubMed ID: 32930115
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of genetic variants in GLUT1 in stage III non-small cell lung cancer treated with radiotherapy.
Kang MK; Lee SY; Choi JE; Baek SA; Do SK; Lee JE; Park J; Yoo SS; Choi S; Shin KM; Jeong JY; Park JY
Thorac Cancer; 2021 Mar; 12(6):874-879. PubMed ID: 33522072
[TBL] [Abstract][Full Text] [Related]
14. The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy.
Koo TR; Moon SH; Lim YJ; Kim JY; Kim Y; Kim TH; Cho KH; Han JY; Lee YJ; Yun T; Kim HT; Lee JS
Radiat Oncol; 2014 Dec; 9():283. PubMed ID: 25498887
[TBL] [Abstract][Full Text] [Related]
15. The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.
Butkiewicz D; Krześniak M; Drosik A; Giglok M; Gdowicz-Kłosok A; Kosarewicz A; Rusin M; Masłyk B; Gawkowska-Suwińska M; Suwiński R
Int J Cancer; 2015 Nov; 137(10):2332-42. PubMed ID: 25975224
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
Wen J; Liu H; Wang Q; Liu Z; Li Y; Xiong H; Xu T; Li P; Wang LE; Gomez DR; Mohan R; Komaki R; Liao Z; Wei Q
Eur J Cancer; 2014 Jul; 50(10):1706-1716. PubMed ID: 24780874
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative radiotherapy as single treatment for early stage non-small cell lung cancer: A single institution analysis.
Zheng X; Sun Y; Ye K; Fan C; Wang X; Yang Y; Jiao R; Ge H
Thorac Cancer; 2021 Mar; 12(6):899-905. PubMed ID: 33529496
[TBL] [Abstract][Full Text] [Related]
18. Radiotranscriptomics signature-based predictive nomograms for radiotherapy response in patients with nonsmall cell lung cancer: Combination and association of CT features and serum miRNAs levels.
Fan L; Cao Q; Ding X; Gao D; Yang Q; Li B
Cancer Med; 2020 Jul; 9(14):5065-5074. PubMed ID: 32458566
[TBL] [Abstract][Full Text] [Related]
19. Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram.
Friedes C; Mai N; Hazell S; Fu W; Han P; Bowers M; Levy B; Forde PM; Voong R; Hales RK
Clin Lung Cancer; 2020 Nov; 21(6):e622-e632. PubMed ID: 32624411
[TBL] [Abstract][Full Text] [Related]
20. Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy.
Chang R; Qi S; Wu Y; Yue Y; Zhang X; Qian W
Cancer Imaging; 2023 Oct; 23(1):101. PubMed ID: 37867196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
